Effect of Huperzine A on Cognitive Function and Perception of Effort During Exercise
Completed · Early Phase 1 · Has a placebo group
Conditions studied: Cognitive Enhancement During Exercise
In brief
This study evaluates the effects of acute huperzine A ingestion prior to exercise on cognitive function and perceived effort in exercise-trained individuals. Huperzine A has shown the ability to improve cognitive function in dementia patients, and is currently marketed as a cognitive enhancing supplement. Study participants will receive either huperzine A or placebo during the first experimental session, and will receive the other substance during the second session.
Key facts
- Study ID
- NCT03445104
- Run by
- St. Louis University
- People needed
- 15
- Starts
- 2018-01-16
- Expected to finish
- 2018-04-05
- Last updated by the study team
- 2018-05-31
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Men and women of all ethnic and racial groups that participate in endurance exercise of moderate to vigorous intensity at least three days per week, for at least 20 minutes per session, for at least six months prior to this study
You may not qualify if…
- Anyone not within the age range listed in section 8a will be excluded. Individuals who require medical clearance to participate in vigorous exercise based on ACSM's risk assessment algorithm will be excluded from the study. The participant screening form will be used to identify signs and symptoms or medical conditions that require medical clearance to participate in vigorous exercise.
Where it is running
- Allied Health Professional Building — St Louis, Missouri, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.